{
  "ticker": "COLL",
  "company_name": "Collegium Pharmaceutical, Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT06431256",
      "title": "Efficacy, Safety & Pharmacokinetic (PK) Study of HLD200 in Children Aged 4-5 Years With ADHD",
      "status": "TERMINATED",
      "phase": "PHASE3",
      "condition": "Attention Deficit Hyperactivity Disorder",
      "start_date": "2024-09-13",
      "completion_date": "2025-07-11",
      "enrollment": 0,
      "sponsor": "Ironshore Pharmaceuticals and Development, Inc"
    },
    {
      "nct_id": "NCT01685684",
      "title": "Oxycodone DETERx\u2122 Versus Placebo in Chronic Low Back Pain (CLBP)",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Chronic Low Back Pain",
      "start_date": "2012-08",
      "completion_date": "2014-07",
      "enrollment": 0,
      "sponsor": "Collegium Pharmaceutical, Inc."
    },
    {
      "nct_id": "NCT03588806",
      "title": "Use of Xtampza ER to Overcome Difficulties in Swallowing Opioid Pills",
      "status": "TERMINATED",
      "phase": "PHASE4",
      "condition": "Chronic Pain, Opioid Use, Deglutition",
      "start_date": "2018-05-01",
      "completion_date": "2019-10-31",
      "enrollment": 0,
      "sponsor": "Ajay Wasan, MD, Msc"
    }
  ],
  "summary": {
    "total_trials": 3,
    "by_phase": {
      "PHASE3": 2,
      "PHASE4": 1
    },
    "by_status": {
      "TERMINATED": 2,
      "COMPLETED": 1
    },
    "active_trials": 0,
    "completed_trials": 1,
    "conditions": [
      "Attention Deficit Hyperactivity Disorder",
      "Chronic Low Back Pain",
      "Chronic Pain, Opioid Use, Deglutition"
    ],
    "lead_stage": "commercial"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:17:37.513847",
    "search_query": "Collegium Pharmaceutical, Inc.",
    "url": "https://clinicaltrials.gov/search?term=Collegium+Pharmaceutical,+Inc."
  }
}